Athira Pharma Inc., located in Bothwell, Washington, has agreed to pay $4,068,698 to resolve allegations that it violated the False Claims Act (FCA) by failing to report allegations of research misconduct to the National Institutes of Health (NIH) and Department of Health and Human Services (HHS) Office of Research Integrity in grant applications and grant award progress Read More
Home » Athira Pharma Inc. Agrees to Pay $4M to Settle False Claims Act
Athira Pharma Inc. Agrees to Pay $4M to Settle False Claims Act
Related Posts
Shipping Company Fined $2M for Maritime Pollution Offense
V.Ships Norway A.S. (V.SHIPS) pleaded guilty to violating the Act to Prevent Pollution from Ships and was sentenced to pay a $2 million fine. V.Ships… BronShipping Company Fined $2M for Maritime Pollution Offense
Former Silicon Valley CEO Charged with Fraud and Obstruction of
A federal grand jury in the Northern District of California returned an indictment charging a Hawaii man with wire fraud, securities fraud, and obstruction in… BronFormer Silicon Valley CEO Charged with Fraud and Obstruction of
Two Self-Professed Religious Leaders Who Used Physical and
A federal grand jury in the Eastern District of Michigan returned a ten-count indictment against two defendants for their alleged roles in a forced labor… BronTwo Self-Professed Religious Leaders Who Used Physical and